Universe Pharmaceuticals INC (UPC) Financial Statements
Universe Pharmaceuticals INC (UPC) files with the U.S. Securities and Exchange Commission under CIK 0001809616. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- $17.86 billion
- Net Income
- -$3.67 billion
- Total Assets
- $69.30 billion
- Net Cash from Operations
- -$5.05 billion
Fiscal year ended Sep 30, 2025. Latest periodic SEC filing: Jan 29, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for UPC in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History